← Clinical Research Coordinator — Hospital Trial Sites
publishedregulation

ICH-GCP

Apply ICH E6(R3) Good Clinical Practice to everyday clinical-trial decisions: protect participants, follow the approved protocol, preserve reliable data, escalate safety issues, document delegated work and respond proportionately when something goes wrong. This is practical GCP literacy for Pharm.D entrants across trial sites, CRO operations, data management, drug safety and clinical quality; it does not award or impersonate an external GCP certificate.

What you will be able to answer

A trial-site file shows consent signed after the first study procedure, a missed protocol visit, an SAE email that was not escalated, a corrected eCRF value with an unclear source and a coordinator performing work absent from the delegation log. What can you produce before the investigator and monitor review the case?

A GCP issue-triage brief that separates participant-rights and safety risks from protocol, data and record failures; maps each issue to the responsible investigator, sponsor or delegated role; identifies the contemporaneous evidence that must be preserved; states the immediate containment and escalation needed; and proposes proportionate corrective and preventive actions without inventing local reporting deadlines or replacing the approved protocol, SOPs and applicable Indian requirements.

Concepts
9
Selected clips
21m 57s
Employers use it
38

One payment

₹99

The videos are free

This is what you pay for

Compared → kept
27 → 9
Full videos → selected
3h 33m → 21m 57s
Concepts
9

Course outline

Learn from selected clips, concept by concept

Concept 1

Read GCP as two linked promises

free

Concept 1 · Read GCP as two linked promises

0:00 / 0:28

Concept 2

Map roles, delegation and oversight

locked

After: gcp-two-promises

A task can move to a coordinator, vendor or CRO; accountability and oversight do not disappear with it.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 21s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 3

Use the protocol, and recognise a deviation

locked

After: roles-delegation-and-oversight

When trial conduct departs from the approved protocol, the first job is to protect the participant and preserve the facts—not relabel the event.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 59s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 4

Treat informed consent as an ongoing process

locked

After: protocol-compliance-and-deviations

A signature records consent; it does not prove that participation was informed, voluntary or still valid after circumstances change.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 48s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 5

Put participant safety before trial routine

locked

After: informed-consent-as-a-process

The first response to a serious safety event is care and escalation; classification and complete follow-up records support that response.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 37s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 6

Control computerised systems across the data lifecycle

locked

After: participant-safety-and-escalation

A compliant platform is not defined by its brand; it is defined by controlled access, reliable operation and a reconstructable data lifecycle.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 26s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 7

Focus quality effort on what matters most

locked

After: protocol-compliance-and-deviations, computerised-systems-and-data-lifecycle

Good quality management concentrates prevention and oversight where errors would meaningfully harm participants or make the result unreliable.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
5m 47s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 8

Respond to noncompliance without hiding the event

locked

After: quality-by-design-and-proportionate-risk

A defensible CAPA contains the immediate risk, explains why the failure occurred and tests whether recurrence was actually prevented.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
3m 50s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 9

Let essential records reconstruct the trial

locked

After: roles-delegation-and-oversight, noncompliance-root-cause-and-capa

Inspection readiness is the ability to reconstruct how the trial protected participants and produced its result—not a clean-up sprint before an audit.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
2m 14s kept
Video review
3 compared

Video title and channel appear once unlocked.

Selection criteria

  • Applies ICH E6(R3) to a clinical-trial decision, document, data change or participant interaction
  • Connects participant protection and reliable results rather than teaching either ethics or documentation in isolation
  • Makes responsibility, escalation and evidence visible through a realistic site, sponsor, CRO or data-management example
  • Distinguishes ICH principles from protocol, SOP and applicable local regulatory requirements
  • Avoids certificate-test coaching, regulation-number memorisation and software-only demonstrations

What was rejected

11 candidates did not meet the course criteria.

  • Structured primarily as a university syllabus lecture; presents rules in list format rather than deeply analyzing GCP as two interdependent ethical and scientific promises.
  • discusses generic research ethics without data reliability
  • Informal monologue that does not work through an actual protocol document or formal protocol amendment example.
  • This video is only a short introductory teaser outlining course objectives without substantive instructional depth.
  • teaches only form completion
  • Provides only a broad regulatory overview without walking through an actual adverse event scenario or detailing escalation steps.
  • This video is a general overview of Site Initiation Visits (SIV) in clinical research and does not detail immediate participant medical care or escalation workflows.
  • High-level AI-generated podcast overview of clinical trial modernization; lacks detailed, actionable operational instruction on specific computerized system lifecycle controls.
  • Provides only a broad introductory overview of QMS principles rather than detailing noncompliance incident response, CAPA steps, or root-cause workflows.
  • Is generic manufacturing CAPA
  • This video is only a promotional curriculum overview and does not provide instructional depth on trial reconstruction.

Where this skill is used

Clinical Data Management — CRO / IT-Pharma

Making clinical-trial data accurate, secure, and analysis-ready: CRF review, query generation and resolution, data cleaning, and database lock. Freshers enter through large IT/BPO hiring drives (TCS, Cognizant, Accenture) and global CROs (IQVIA, ICON, Parexel) — no coding needed at entry. Honest caveat: your clinical training gives little edge here; B.Pharm, life-science, and IT graduates compete equally, and software/SQL skills matter more than therapeutics.

10 mapped employers

Explore path →

Clinical QA / GCP Auditor — Quality & Process Excellence

Auditing clinical-trial sites, vendor facilities, and TMF documentation for Good Clinical Practice compliance ahead of regulatory inspections. Manufacturing QC/QA is B.Pharm/M.Pharm territory, but clinical QA fits the Pharm.D. Direct entry is impossible — auditors need deep operational knowledge, so the route is 3–5 years in clinical operations (CTA/CRC), PV, or data management first, then the pivot to quality.

7 mapped employers

Explore path →

Clinical Research Associate — Site Monitoring

The sponsor's field liaison to hospital trial sites. You travel to sites to conduct Source Data Verification, audit protocol adherence, and monitor patient safety. Direct fresher entry is rare due to regulatory risk — the standard route is 1–2 years as a CTA or CRC first, then Junior CRA. Well-paid and high-autonomy, but monitoring travel of 50–80% is the defining lifestyle trade.

9 mapped employers

Explore path →

Clinical Research Coordinator — Hospital Trial Sites

Site-based trial coordination at hospitals and Site Management Organizations — the most direct use of your Pharm.D hospital exposure in clinical research. You screen and schedule trial participants, support informed consent, maintain the Investigator Site File, coordinate lab samples, and enter data into eCRFs. Your internship-year hospital network is often the hiring pipeline. A common springboard to CRA roles on the sponsor side.

9 mapped employers

Explore path →

Clinical Trial Assistant / eTMF Specialist — CRO

The administrative backbone of clinical-trial execution and a standard fresher door into clinical operations. You maintain the electronic Trial Master File (eTMF), update Clinical Trial Management Systems (CTMS), track regulatory documents, and coordinate clinical supplies at a CRO. Heavy documentation in year one, then the CRA gate opens at 1–2 years — this is the proven stepping-stone path.

8 mapped employers

Explore path →

Drug Safety Associate — Pharmacovigilance (CRO / Pharma MNC)

The single most common corporate landing spot for Pharm.D freshers in India. You process Individual Case Safety Reports (ICSRs) — extracting adverse-event data, assessing causality, coding with MedDRA, and writing safety narratives — inside CROs and IT-pharma units (TCS, Cognizant, Accenture, IQVIA). Your clinical training gives a genuine edge in causality assessment and narrative writing over B.Pharm competitors. Progression runs from case processing to aggregate reports (PSURs/PBRERs) to signal detection and PV management.

12 mapped employers

Explore path →